Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diageo plc (DEO) vs Edwards Lifesciences Corporation Common Stock (EW) Price & Performance

Diageo plcTrade
Edwards Lifesciences Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

Diageo plc vs Edwards Lifesciences Corporation Common Stock — how do they compare? Diageo plc trades at $86.83 (market cap $47.67B), while Edwards Lifesciences Corporation Common Stock trades at $85.19 (market cap $48.56B). The key difference: Diageo plc and Edwards Lifesciences Corporation Common Stock are close in size by market cap, and Diageo plc pays a 2.3% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.

DEOEW
Market Cap
$47.67B$48.56B
Volume
893,3726,520,488
Sector
Consumer StaplesHealth
52-Week High
$102.14$95.18
52-Week Low
$72.47$72.65
Typical Hold Time
66 Days—
Enterprise Value
$68.09B$45.01B
Dividend Yield
2.3%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Diageo plc

Diageo (DEO) trades at $86.73, up 2.36% with bullish technical indicators and strong analyst support. The company demonstrates solid fundamentals with consistent earnings beats, a 15.82% ROE, and positive cash flow generation. Recent corporate developments include a new CFO appointment and marketing initiatives across key brands, though revenue declined to $19.6B in 2026 with margin compression.

The stock presents a compelling turnaround opportunity with analyst consensus favoring bullish sentiment (48.65% buy ratings). Key catalysts include cost-saving initiatives and brand revitalization, while risks involve US market challenges, regulatory scrutiny in India, and ongoing margin pressure. The current valuation at 27.91 P/E appears reasonable given the growth potential.

Edwards Lifesciences Corporation Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Diageo plc

Diageo is a global leader in beverage alcohol with an outstanding collection of brands including Johnnie Walker, Smirnoff, and Guinness. It operates a vast portfolio of spirits and beers across more than 180 countries.

Read more on DEO →

About Edwards Lifesciences Corporation Common Stock

Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.

Read more on EW →